Update of Newborn Screening and Therapy for Congenital Hypothyroidism
Top Cited Papers
Open Access
- 1 June 2006
- journal article
- review article
- Published by American Academy of Pediatrics (AAP)
- Vol. 117 (6), 2290-2303
- https://doi.org/10.1542/peds.2006-0915
Abstract
Unrecognized congenital hypothyroidism leads to mental retardation. Newborn screening and thyroid therapy started within 2 weeks of age can normalize cognitive development. The primary thyroid-stimulating hormone screening has become standard in many parts of the world. However, newborn thyroid screening is not yet universal in some countries. Initial dosage of 10 to 15 μg/kg levothyroxine is recommended. The goals of thyroid hormone therapy should be to maintain frequent evaluations of total thyroxine or free thyroxine in the upper half of the reference range during the first 3 years of life and to normalize the serum thyroid-stimulating hormone concentration to ensure optimal thyroid hormone dosage and compliance.Improvements in screening and therapy have led to improved developmental outcomes in adults with congenital hypothyroidism who are now in their 20s and 30s. Thyroid hormone regimens used today are more aggressive in targeting early correction of thyroid-stimulating hormone than were those used 20 or even 10 years ago. Thus, newborn infants with congenital hypothyroidism today may have an even better intellectual and neurologic prognosis. Efforts are ongoing to establish the optimal therapy that leads to maximum potential for normal development for infants with congenital hypothyroidism.Remaining controversy centers on infants whose abnormality in neonatal thyroid function is transient or mild and on optimal care of very low birth weight or preterm infants. Of note, thyroid-stimulating hormone is not elevated in central hypothyroidism. An algorithm is proposed for diagnosis and management.Physicians must not relinquish their clinical judgment and experience in the face of normal newborn thyroid test results. Hypothyroidism can be acquired after the newborn screening. When clinical symptoms and signs suggest hypothyroidism, regardless of newborn screening results, serum free thyroxine and thyroid-stimulating hormone determinations should be performed.Keywords
This publication has 86 references indexed in Scilit:
- Definitive diagnosis in children with congenital hypothyroidismThe Journal of Pediatrics, 2004
- Thyroid abnormalities by ultrasonography in neonates with congenital hypothyroidismThe Journal of Pediatrics, 2003
- Congenital HypothyroidismPediatric Drugs, 2003
- Subclinical Hypothyroidism in Early Childhood: A Frequent Outcome of Transient Neonatal HyperthyrotropinemiaJournal of Clinical Endocrinology & Metabolism, 2002
- Reference Intervals from Birth to Adulthood for Serum Thyroxine (T4), Triiodothyronine (T3), free T3, free T4, Thyroxine Binding Globulin (TBG) and Thyrotropin (TSH)cclm, 2001
- Follow-up of newborns with low thyroxine and nonelevated thyroid-stimulating hormone–screening concentrations: Results of the 20-year experience in the Northwest Regional Newborn Screening ProgramThe Journal of Pediatrics, 1998
- Age-adjusted thyrotropin criteria for neonatal screening for hypothyroidismThe Journal of Pediatrics, 1990
- Longitudinal assessment of l-thyroxine therapy for congenital hypothyroidismThe Journal of Pediatrics, 1990
- Detection of congenital hypopituitary hypothyroidism: Ten-year experience in The Northwest Regional Screening ProgramThe Journal of Pediatrics, 1986
- Preliminary report on a mass screening program for neonatal hypothyroidismThe Journal of Pediatrics, 1975